Consensus NurExone Biologic Inc.

Equities

NRX

CA67059R1091

Delayed Toronto S.E. Other stock markets 03:39:16 2024-05-17 pm EDT			5-day change	1st Jan Change
0.49 ^CAD	-2.00%		-12.50%	+66.10%

Apr. 25	NurExone Biologic Announces OTCQB Listing And DTC Eligibility	MT
Apr. 02	NurExone Biologic Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Evolution of the average Target Price on NurExone Biologic Inc.

Price target over the last 5 years

History of analyst recommendation changes

446080f690c963151f8c31323e.mUsmIEBixJMTFoVxfXy7YTD8MDduASwVF33Y9Y8VWJ8.0wx0QhIpq-JGVOk4Sy7UGGCTX3gJVF53JTuxhdlvAs3zMkl3FTP95V1DzA~9160ae81fee47e8782f7a0e1392edb79

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.3601 USD

Average target price

2.907 USD

Spread / Average Target

+707.18%

High Price Target

2.907 USD

Spread / Highest target

+707.18%

Low Price Target

2.907 USD

Spread / Lowest Target

+707.18%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar